PT  - JOURNAL ARTICLE
AU  - Alexander, Lori
ED  - Roe, Matthew T.
TI  - TRILOGY ACS Outcomes
DP  - 2012 Nov 01
TA  - MD Conference Express
PG  - 12--12
VI  - 12
IP  - 13
4099  - http://mdc.sagepub.com/content/12/13/12.short
4100  - http://mdc.sagepub.com/content/12/13/12.full
AB  - In the largest trial to date of patients with medically managed acute coronary syndrome without revascularization, prasugrel did not improve outcomes, compared with clopidogrel during 2.5 years of follow-up among patients <75 years. The findings are from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes [TRILOGY ACS] study [Roe MT et al. N Engl J Med 2012].